| Muscle-specific receptor tyrosine kinase (MuSK) myasthenia gravis associated with castleman disease |
| Jeeyoung Oh1, Woo Ick Yang2, Jeong Hoon Cho3, and Il Nam Sunwoo4 |
1Department of Neurology, Konkuk University School of Medicine, Seoul, Korea
2Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
3Purunsol Neurology Clinic, Incheon, Korea
4Sunwoo & Cho Neurology Clinic, Seoul, Korea |
| Corresponding Author:
Il Nam Sunwoo ,Tel: +82-2-2268-1400, Fax: +82-2-2268-4400, Email: sunwooin@yuhs.ac |
|
Received November 8, 2016 Revised: December 16, 2016 Accepted December 20, 2016 |
| Copyright © 2017 The Korean Society of Clinical Neurophysiology |
| This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,
provided the original work is properly cited. |
| ABSTRACT |
|
Muscle specific tyrosine kinase (MuSK) myasthenia gravis (MG) is a rare subtype of MG, which is immunologically distinct and differential therapeutic response. Though MG is often associated with other autoimmune disorders or malignancy, concurrence of other disease and MuSK MG has been infrequently reported. We present a patient of MuSK MG associated with multicentric Castelman disease. |
| Key words:
Castleman disease; Myasthenia gravis; Muscle specific tyrosine kinase |
|
|
|
PDF Links
Download Citation 
Print 
